Infectious Disease Snapshots: 6 Studies for Primary Care

News
Slideshow

How prevalent is use of antibiotics without a prescription? How effective is HCV treatment in people who inject drugs? See snapshots of these study results and 4 more.

These 6 short takes offer details on recent studies that looked at prevalence of antibiotic use without a prescription; HBV screening during pregnancy; feasibility of HCV treatment among PWID; poor outcomes in older adutls with encephalitis; and, reasons for vaccination hesitancy. 

Recent Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Interview with Kelly Moore, MD, MPH, president, chief executive officer, Immunization Action Coalition
Related Content
Direct Mail to Older Adults at Risk for Pneumococcal Disease Improves Vaccination Rates / image credit ©Kateryna_Kon/stock.adobe.com

Direct Mail to Older Adults at Risk for Pneumococcal Disease Improves Vaccination Rates

Grace Halsey
April 2nd 2025
Article

A mail campaign targeting adults with chronic conditions as well as their GPs increased the number receiving at least 1 shot by 9.5 percentage points.

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Keith A. Reynolds
October 1st 2024
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Steven P. Furr, former president of the American Academy of Family Physicians.

FDA logo ©Araki Ilustrations/AdobeStock

FDA Authorizes Marketing of First At-Home Test for Chlamydia, Gonorrhea, Trichomoniasis

Sydney Jennings
March 31st 2025
Article

The Women’s Sexual Health Test (Visby Medical) delivers results in approximately 30 minutes using a vaginal swab.

Respiratory Tripledemic 2022-23: An Expert Recap

Respiratory Tripledemic 2022-23: An Expert Recap

Sydney Jennings
April 6th 2023
Podcast

William Schaffner, MD, medical director of the NFID, provides an expert recap of the 2022-2023 respiratory virus season for primary care clinicians.

Sanofi's Chlamydia Vaccine Granted FDA Fast Track Designation / Image credit: ©Dr_Microbe - ©Dr_Microbe - stock.adobe.com

Sanofi's Chlamydia Vaccine Granted FDA Fast Track Designation

Sydney Jennings
March 26th 2025
Article

The FDA granted fast track designation to Sanofi’s chlamydia vaccine candidate today, aiming to prevent infections and address an unmet public health need.

FDA Approves Gepotidacin (Blujepa) for Treatment of Uncomplicated UTIs

FDA Approves Gepotidacin (Blujepa) for Treatment of Uncomplicated UTIs

Sydney Jennings
March 25th 2025
Article

Gepotidacin is the first new oral antibiotic for uncomplicated urinary tract infections in 30 years, offering an alternative amid rising antibiotic resistance.

© 2025 MJH Life Sciences

All rights reserved.